FLT3 and acute myeloid leukemia: Fms-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) mutations occur in approximately 30% of adult acute myeloid leukemia (AML) patients and are associated with poor clinical outcomes (1), particularly in patients with higher mutant-to-wild type (WT) allelic ratios (2).